Ozempic’s Success Is Bad News for Rivals

Madison Muller, Bloomberg News Health Reporter, discusses the drug Ozempic and its potential to treat various health conditions such as kidney disease, heart disease, Alzheimer's, and alcohol use disorder. The podcast explores the groundbreaking effects of GLP1 receptor agonists in treating diabetes and promoting weight loss. It also delves into the potential benefits and implications of weight loss treatments and the recent popularity of using diabetes drugs for weight loss.